In an interview with entrepreneur Peter Diamandis on Tuesday, Musk shared that the tech industry was already undertaking "atomic level assembly" on circuits, sharing that there were four or five ...

Ian Easterling, a biologist with the Conservancy of Southwest Florida, captured a 153-pound female Burmese python, one of the largest caught in Florida in 2025. Conservancy of Southwest ...

Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...

Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech. The new firm, Ambros Therapeutics, debuted Tuesday with a $125 million series A and plans to develop a ...

Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has ...

WASHINGTON — House lawmakers unanimously passed legislation Wednesday aimed at preventing terrorists from using generative artificial intelligence (AI) amid fears that the technology could help ...

Turning a boring 2D photo into a more dynamic, 3D-like viewing experience might sound impossible. But you can do it right from your phone running iOS 26, thanks to Apple's new Spatial Scenes. Apple's ...

A team of Mayo Clinic scientists have created a way to estimate a person’s risk of developing memory and thinking problems long before symptoms of Alzheimer’s disease begin, potentially changing how ...

Last month, FBI Director Kash Patel announced that the Secret Service discovered a “suspicious” hunting stand near Palm Beach International Airport with a direct sight line to where President Donald ...

SDLC guides teams to plan, build, test, and deliver software. Discover phases, KPIs, tools, and checklist with our quick start guide. Picture this: You and your team have spent a tremendous amount of ...

WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for immunological, inflammatory, and ...